THE TURKISH ASSOCIATION OF PSYCHOPHARMACOLOGY (TAP):
The TAP was founded in 2005, with the intention
of bringing together those from clinical and experimental disciplines as
well as members of the pharmaceutical industry involved in the study of
psychopharmacology, and to advance scientific understanding of and to
facilitate communication about disorders of the brain and behavior in order
to advance their prevention and treatment.
The principal function of the TAP is to further research and education in neuropsychopharmacology
and related fields by: promoting the interaction of a broad range of
scientific disciplines of brain and behavior in order to advance the
understanding of prevention and treatment of diseases of the nervous system
including psychiatric, neurological, behavioral and addictive disorders,
encouraging scientists to enter research careers in fields related to these
disorders and their treatment, and ensuring the dissemination of relevant
scientific advances in these disorders.
The TAP arranges scientific
meetings, fosters research and teaching, encourages publication of results
of research and provides guidance and information to the public on matters
relevant to psychopharmacology. The TAP organizes scientific meetings and
symposia during the course of the year, covering all aspects of
psychopharmacology from basic research to pharmaceutical development and
clinical application. The Association is planning to begin to produce a
range of consensus statements on the treatment of clinical disorders. The
TAP is planning to launch a program for Continuing Professional Development
and Certificate in Clinical Psychopharmacology, which will be related to
Anxiety Disorders, Schizophrenia and Affective Disorders, Substance Misuse,
Drug Treatments in Old Age Psychiatry and Child and Adolescent
Psychopharmacology.
Psychopharmacology
is the single most effective treatment modality in psychiatry. It is vital we use drugs to their optimal
effect - matching our choices and regimes to the needs and symptoms of
patients whilst minimizing side effects and avoiding adverse interactions
with other drugs. New, often better drugs and new ways of using old ones
appear by the month. With ever increasing demands on our professional time
it is difficult to keep up to date.
The TAP supports the use of animals in biomedical research in Turkey, which
is essential and unavoidable, and the continuing, thorough scrutiny of this
research. The TAP supports the effort to find new ways of treating
debilitating (sometimes life-threatening) psychiatric disorders such as
depression, schizophrenia and dementia. Members of the TAP are dedicated to
ensuring best practice in psychiatry and acknowledge that this requires the
evaluation of existing medicines as well as the discovery and developments
of new ones. Psychopharmacology research recruits a wide range of
techniques including those using isolated cells and tissues, as well as
experiments on humans. Nevertheless, it is still necessary to understand
how drugs affect whole animal physiology and behavior. Research using
animals has made, and continues to make, a vital contribution to this
process.
1.Turkish
Association For Psychopharmacology (TAP) Grants:
1a. Definition :
The Turkish Association for
Psychopharmacology awards this grant in order to provide financial support
to scientists, in accordance with the categories listed below or possessing
the required high qualifications, to conduct work or study in the fields of
biological psychiatry in countries outside Turkey.
The Association Board of Directors is obliged to compile a selection
committee to select the scientists that to be supported and to provide the
funds governing the grant. The Association Board of Directors shall have
the right at any time to temporarily postpone or cancel this grant in any
such situation that it may not be in a position to provide sufficient funds
into the grant. The Association Board of Directors shall notify the number
of grants that it will award and their categories, no less than 6 months
before the Clinical Psychopharmacology Congress. For the year 2008, there
shall be one grant each awarded from categories I and II.
The financial support shall cover the transportation costs (economy class
return), health insurance for 3 month duration and a monthly spending
allowance of 1500 USD of the scientist.
1b.Category I: TAP Young Researcher Grant
This grant can be
applied to by psychiatry and pharmacology assistants who have completed
their 2nd year and by psychiatry and pharmacology specialists
(Associate-Professors incl.), under the age of 40, who are currently
working for an educational institution.
The applications must
be submitted together with the yearly National Congress on
Psychopharmacology (NCP) poster applications.
1b1.Requirements from applicants:
Applicant must submit
at least 1 poster to the poster competition at the NCP.
Full resume and list of
publications.
The applicant must send
together with his application, documentation to prove that 65 or more
points have been awarded from the UDS (or its equivalent).
A 1250-1500 word text
in ENGLISH, stating the applicant’s opinion on the future of psychiatry and
the role that the applicant would like play within that future.
A letter of reference
of the applicant from the head of the educational establishment at which
the applicant works (supervisor, department head, dean)
The applicants that
chosen to receive grants, from within the top five of the winners of the
pre-requisite poster competition shall be notified at the award ceremony at
the end of the congress.
1c. Category II: TAP Career Development Grant
This grant can only be applied for by
associate-professors and professors who are currently involved in active
scientific research or those providing education in the fields of
psychiatry or psychopharmacology. There is no age limit but the applicant
must posses high scientific qualities and must posses research that has
made a contribution to world science literature during the application
process for this grant. A letter of application must be presented to The
Turkish Association for Psychopharmacology Board of Directors, no less than
1 month before the NCP congress, notifying that the applicant wishes to be
considered for the prize. During the application process, the applicant
must provide a resume containing a list of publications, a 1250-1500 word
text in ENGLISH, stating the applicant’s opinion on the future of
psychiatry and the role that the applicant would like play within that
future, the applicant’s three most important works and the country and
centre the applicant wishes to go to with the Grant.
1d. Duration of TAP Career Development Grant:
The successful applicants must notify the
association board of directors within 6 months of the NCP, of the centre
and country that the applicant –shall go to and the letter of acceptance
from that centre, together with other relevant details (leaving and
returning dates, bank account numbers, etc). Under association policies,
this grant is awarded as an aim to provide support for employees in the
field of biological psychiatry, therefore, it shall be required that the
centre of study that conducts biological psychiatry research. Grants may be
cancelled in the event that suitable centres are not provided by the applicant.
This decision shall be at the discretion of the association board of
directors.
The applicant must use the grant within 12 months of being awarded.
Travel and insurance together with the first months grant shall be paid
into the applicant’s bank account prior to departure. The following two
months’ payments shall be made into an account held at an active Turkish
Republic bank.
On their return, applicants shall present the association board of
directors with a summarised report of their studies abroad and share these
studies with their colleagues by giving a talk at following NCP.
Following the award of the grant, in the event of behaviour by the
applicant contrary to that of the laws of the Republic of Turkey; or
employment ethics rules and regulations during the time allocated to
complete studies abroad within the framework of the grant, the applicant
shall be taken out of the grant program and a repayment of all payments
(travel, insurance inclusive) made until the time of cancellation shall be demanded
in return.
2.PAST ACTIVITIES of the TAP:
2a. FIRST NATIONAL PSYCHOPHARMACOLOGY CONGRESS ( 1st
NPC):
The first NPC will take place in Istanbul, Turkey, on December 14- 17 th, 2005.
At the 1st NPC,
distinguished Turkish and international scientists ( Bill
Deakin,
Serdar
Dursun, Stan Kutcher, Norbert Muller,and Jim van Os) brougth
the latest developments in psychopharmacology through conferences, panels, and
satellite symposiums to the agenda, and participate in scientific discussions.
At this congress, “Meet the Expert” sessions and workshops have been organized by the prominent scientists in their
fields.
We hereby especially and
kindly request you to complete the section included in this announcement with
your views and recommendations embedded in and relay the same to us, since we
consider realization of this congress with cooperative production and partake
of all participants important and for that we believe in it.
I wish meeting you at 1st
NPC, in Istanbul which is not an
intercontinental city, a bridge between Asia and Europe, but the most famous
and historical city of Turkey. (http://www.psikofarmakolojikongresi2005)
2a1.Some photographs from
1st NPC:
Mesut Cetin, Serdar Dursun and Norbert Muller
at giving plaque ceremony.
Mesut Cetin and Serdar Dursun at
giving plaque ceremony..
Mesut Cetin, and winners at award ceremony.
Suha Ozaskinli, and winners at award ceremony.
2b. SECOND NATIONAL PSYCHOPHARMACOLOGY CONGRESS:
On June 21-24th 2007 the
Turkish Association for Psychopharmacology (TAP) launched
Second National Congress on Psychopharmacology (The 2nd NPC ) .The 2nd NPC has been the continuation and the 6th of the Progress in Clinical Psychopharmacology-
International Symposium , organized by the PDGHTH, which had been taken place
five times between 1991 and 1998, and second of the national psychopharmacology congress organized by the TAP in December 14-17th 2005 at Istanbul.
Latest developments in psychopharmacology have been presented as lectures, panels, round table
meetings and satellite symposiums by prominent national and international
contributors
Jayne
Bailey, Glen B. Baker, Philip Cowen, Tim Crow, Bill Deakin,
Serdar
Dursun, Guy Goodwin, Stan Kutcher, Norbert Muller, David Nutt,
Trevor Robbins, and Atilla Turgay at the 2nd NPC. (http://www.psikofarmakolojikongresi2007)
2b1.Some photographs from 2nd NPC:
Opening speech by Honorary President Yusuf Ziya
Yergok,
Atilla Turgay’s Lecture:
Bill Deakin’s Lecture:
David Nutt’s Lecture:
David Nutt’s
speech at the Gala Dinner:
Glen Baker’s Lecture:
Guy Goodwin’s Lecture:
Jayne Bailey’s Lecture:
Norbert
Muller’s Lecture:
Philip Cowen’s Lecture:
Serdar Dursun’s Lecture:
Stan Kutcher’s Lecture:
Stan Kutcher’s Workshop:
Tim Crow’s Lecture:
Tim Crow’s
Round Table
Trevor Robin’s Lecture:
Trevor Robin’s Round Table:
2c. PSYCHOPHARMACOLOGY THERAPEUTICS UPDATE 2008:
Further
to the excellent feedback on the 2nd National Psychopharmacology Congress, TAP
had requests to develop and initiate further educational activities involving
frontline prescribing guidelines, daily clinical practice and
psychopharmacology and clinical therapeutics.
TAP will be coordinating such a special
congress to address “Therapeutics Update in Psychopharmacology” once every two
years. The first of the “Therapeutics update” took
place in Antalya between January 29-31, 2008. In
addition to excellent national teachers and speakers, we also had excellent
international contribution and speakers including David
Baldwin, Robert Palmer, John Cookson, David Osser, Harold Robertson, Malcolm
Lader, Axel Wurz and Serdar Dursun.
Therapeutics Update in Psychopharmacology 2008
were designed to address day to
day clinical psychopharmacological problems in psychiatry facing clinicians.
Furthermore, psychopharmacological guidelines have been presented and also there were been taken place discussions
on therapeutic options for treatment-resistant patients and the future of psychopharmacology and present
therapeutic hopes for patients with mental illness. (http://www.psikofarmakolojiupdate2008.org/)
2c1.Some photographs from
TAP Psychopharmacology Therapeutics Update 2008 Meeting:
Opening Speech by Congress President Mesut Cetin
Feyza Aricioglu’s Lecture:
Emin Ceylan's Lecture:
Serdar Dursun's Lecture:
John Cookson's Lecture:
Robert Palmer's Lecture:
David Baldwin's Lecture:
David Osser's Lecture:
Harold
Robertson's Lecture:
The audience at
the TAP Psychopharmacology Therapeutics Update 2008 Meeting-1:
The audience at
the TAP Psychopharmacology Therapeutics Update 2008 Meeting-2:
The audience at
the TAP Psychopharmacology Therapeutics Update 2008 Meeting-3:
2d. THIRD TURKISH NATIONAL CONGRESS ON PSYCHOPHARMACOLOGY:
The Third National Congress
on Psychopharmacology will take place in Istanbul, Turkey, on March12-15th,
2009. At the 3rd NPC latest
developments in psychopharmacology will be
presented as lectures, panels, round table meetings and satellite
symposiums by prominent national and international contributors Bill Deakin,
Serdar
Dursun, John Geddes,S.Nasir Ghaemi, John Kane, Stan Kutcher, Herbert
Meltzer, Norbert Muller, Andrew Nierenberg,David Nutt, David Osser,Ronald
Pies,Michael Thase, and Nora Volkow.
3- PUBLICATIONS of TAP:
3a. Bulletin of
Clinical Psychopharmacology (Klinik Psikofarmakoloji Bülteni) has been published in Turkish and English
since 1990. The website of this journal is
http://www.psikofarmakoloji.org.
Klinik Psikofarmakoloji Bulteni (Bulletin of
Clinical Psychopharmacology) is indexed in
EMBASE (Excerpta Medica),
PsychINFO/Psychological
Abstracts,
PsycSCAN:
Psychopharmacology,
Curent
Awareness in Biological Sciences (CABS),
Chemical Abstracts(CAS),
Elsevier BIOBASE,
International
Pharmaceutical Abstracts (IPA), Index
Copernicus,
ISI
Master Journal List,
EBSCO
host Current Abstracts,
EbscoHost TOC premie,
ProQuest
Health & Medical Complete ,
ProQuest
Psychology,
DOAJ,
Scopus and
TÜBÝTAK
Medical
Index.
3b.Some Turkish desk reference and handbooks in clinical psychiatry
